ENG/中
老虎證券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Bayer A.G.
15.66
-0.0100
-0.06%
盤後:
15.66
0.0000
0.00%
16:00 EST
成交量:
54.44萬
成交額:
852.31萬
市值:
615.39億
市盈率:
-37.45
高:
15.72
開:
15.63
低:
15.60
收:
15.67
52周最高:
15.98
52周最低:
7.65
股本:
39.30億
流通股本:
39.29億
量比:
0.34
換手率:
0.01%
股息:
0.03
股息率:
0.20%
每股收益(TTM):
-0.4181
每股收益(LYR):
-0.6723
淨資產收益率:
-4.56%
總資產收益率:
4.34%
市淨率:
1.91
市盈率(LYR):
-23.29
資料載入中...
總覽
公司
新聞資訊
公告
輝瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)尋求駁回拜耳旗下孟山都mRNA專利訴訟遭法官拒絕
智通财经
·
09/29
拜耳(BAYRY)腎病藥物可仁達®獲FDA批新適應症 填補1型糖尿病併發症30年空白
金吾财讯
·
09/17
阿波羅(APO)聯合KKR(KKR)完成對拜耳(BAYRY)30億歐元資本解決方案交易
金吾财讯
·
09/16
拜耳(BAYRY)二季度Non-GAAP每股盈利達0.95歐元勝預期
金吾财讯
·
08/04
財報前瞻|Bayer A.G.本季度營收預計降4.47%,機構觀點偏多
财报Agent
·
07/28
拜耳(BAYRY)旗下長效可逆避孕業務引入阿波羅(APO)30億歐元戰略投資
金吾财讯
·
07/10
拜耳(BAYRY)拆分美國草甘膦業務設立全資子公司 全新實體優化農化市場運營
金吾财讯
·
07/02
美國最高法院裁定拜耳(BAYRY)在「農達」除草劑訴訟案中勝訴
金吾财讯
·
06/26
拜耳(BAYRY)與Iambic攜手利用AI加速藥物研發
金吾财讯
·
06/22
拜耳(BAYRY)股價承壓下行 與農達除草劑和解協議面臨新的法律挑戰
金吾财讯
·
06/02
拜耳(BAYRY)新藥獲FDA優先審評 腎科用藥版圖擴容
金吾财讯
·
05/21
拜耳(BAYRY)新藥獲FDA優先審評 聚焦二次中風預防
金吾财讯
·
05/19
律師們在拜耳72.5億美元和解案中爭取接近紀錄的律師費
路透中文
·
05/15
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/BAYRY/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BAYRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BAYRY\",,,,,undefined,":{"symbol":"BAYRY","market":"US","secType":"STK","nameCN":"Bayer A.G.","latestPrice":15.66,"timestamp":1794603600000,"preClose":15.67,"halted":0,"volume":544421,"hourTrading":{"tag":"盘后","latestPrice":15.66,"preClose":15.66,"latestTime":"16:00 EST","volume":1298,"amount":20315.940000000002,"timestamp":1794603640964,"change":0,"changeRate":0,"amplitude":0.000639},"delay":15,"changeRate":-0.000638162093171652,"floatShares":3929259738,"shares":3929696328,"eps":-0.41815,"marketStatus":"已收盤","change":-0.01,"latestTime":"11-13 16:00:40 EST 延時","open":15.63,"high":15.715,"low":15.6,"amount":8523143.572799996,"amplitude":0.007339,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.41815,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":5,"adr":0,"adrRate":0.25,"exchange":"OTCQX","adjPreClose":15.67,"volumeRatio":0.34397},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BAYRY\",,,,,undefined,":{"symbol":"BAYRY","floatShares":3929259738,"roa":"4.34%","roe":"-4.56%","lyrEps":-0.672343,"volumeRatio":0.34397,"shares":3929696328,"dividePrice":0.031526,"high":15.715,"amplitude":0.007339,"preClose":15.67,"low":15.6,"week52Low":7.65,"pbRate":"1.91","psRate":"1.22","week52High":15.98,"institutionHeld":0.0017,"latestPrice":15.66,"eps":-0.41815,"divideRate":0.002013,"volume":544421,"delay":15,"ttmEps":-0.41815,"open":15.63,"prevYearClose":10.82,"prevWeekClose":15.33,"prevMonthClose":13.99,"prevQuarterClose":13.5,"fiveDayClose":15.33,"twentyDayClose":12.47,"sixtyDayClose":14.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BAYRY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-12","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"","actualEps":null},{"date":"2026-04-28","symbol":"BAYRY","amount":0.031526,"announcedDate":"2026-04-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-28","defaultRemindTime":1777383000000,"name":"Bayer A.G.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-11","payableDate":"2026-04-28","currency":"USD","dateTimestamp":1777348800000,"payDate":"2026-05-11"},{"market":"US","date":"2025-05-13","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"","actualEps":null},{"date":"2025-04-29","symbol":"BAYRY","amount":0.030365,"announcedDate":"2025-04-04","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-29","defaultRemindTime":1745933400000,"name":"Bayer A.G.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-12","payableDate":"2025-04-29","currency":"USD","dateTimestamp":1745899200000,"payDate":"2025-05-12"},{"market":"US","date":"2024-11-12","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BAYRY\",market:\"US\",,,undefined,":[{"executeDate":"2019-04-29","recordDate":"2019-04-30","paymentDate":"2019-05-13","value":0.550569,"currency":"USD"},{"executeDate":"2020-04-29","recordDate":"2020-04-30","paymentDate":"2020-05-14","value":0.535933,"currency":"USD"},{"executeDate":"2021-04-28","recordDate":"2021-04-29","paymentDate":"2021-05-10","value":0.407111,"currency":"USD"},{"executeDate":"2022-05-02","recordDate":"2022-05-03","paymentDate":"2022-05-16","value":0.549114,"currency":"USD"},{"executeDate":"2023-05-02","recordDate":"2023-05-03","paymentDate":"2023-05-15","value":0.6318,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BAYRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":3,"updateTime":1783918800000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BAYRY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671326261","title":"輝瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)尋求駁回拜耳旗下孟山都mRNA專利訴訟遭法官拒絕","url":"https://stock-news.laohu8.com/highlight/detail?id=2671326261","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671326261?lang=zh_tw&edition=fundamental","pubTime":"2026-09-29 10:28","pubTimestamp":1790648936,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,美国特拉华州一名联邦法官周一驳回了辉瑞、BioNTech和Moderna提出的请求。这三家公司此前要求驳回德国医药巨头拜耳旗下孟山都针对它们提起的诉讼,该诉讼涉及这些制药公司对一项与mRNA技术相关专利的使用。要知道,辉瑞/BioNTech的疫苗Comirnaty已创下超930亿美元的销售额,这也让拜耳的维权诉求更受关注。Moderna曾辩称,该专利涉及的是不可授予专利的“自然法则”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0792757196.USD","IE00BSNM7G36.USD","LU1551013425.SGD","LU1585245621.USD","LU0545562505.USD","BK4559","LU2750360641.GBP","IE00B7SZLL34.SGD","LU1894683348.USD","LU2471134523.USD","BNTX","LU0225284248.USD","LU1430594728.SGD","LU2133065610.SGD","LU0234570918.USD","LU0057025933.USD","LU1983299246.USD","LU1043141123.HKD","LU1935042991.SGD","LU0289961442.SGD","LU1291159041.SGD","BK4568","LU0289739699.SGD","LU0203345920.USD","SGXZ57979304.SGD","LU1244550577.SGD","LU1066053197.SGD","LU2129689431.USD","IE00BKVL7J92.USD","IHE","LU1883839398.USD","LU2112291526.USD","IE00B3T34201.USD","LU2471134879.HKD","XLV","LU0053666078.USD","LU0072461881.USD","LU0820562030.AUD","LU0949170772.SGD","LU2756315664.SGD","SG9999011175.SGD","LU0345769128.USD","IE00BN8TJ469.HKD","LU2417539215.USD","IE000BZT7R73.USD","IE00BDGV0183.EUR","LU2023250330.USD","LU0943347566.SGD","LU1032466523.USD","LU0868494617.USD","BK4548","LU1003077747.HKD","LU0114720955.EUR","BK4139","LU0787776722.HKD","LU2896262040.SGD","BK4532","LU0683600562.USD","LU0795875086.SGD","BK4585","IE00B1BXHZ80.USD","LU1551013342.USD","LU1023059063.AUD","LU1121112475.USD","LU1228905037.USD","IE00B42XCP33.USD","LU0889566641.SGD","PJP","LU0994945656.USD","BK4599","LU0058720904.USD","PFE","IE00BBT3K403.USD","BK4588","IE0002270589.USD","LU1162221912.USD","LU2468319806.SGD","LU1066051225.USD","LU0234572021.USD","LU2347655156.SGD","LU0321505439.SGD","BK4504","LU2505996509.AUD","LU1228905540.USD","LU1061106388.HKD","LU2236285917.USD","LU0210528500.USD","IE0002141913.USD","LU0098860793.USD","LU0553294199.USD","BK4534","IE000F7OJYX1.SGD","LU1778281490.HKD","LU2129689605.HKD","IE00BJT1NW94.SGD","LU0345770308.USD","MRNY","LU1221951129.SGD","LGHT","BAYRY","IE00B19Z3581.USD","OZEM","FTXH","LU0345769631.USD","LU1496350502.SGD","LU0882574055.USD","LU1074936037.SGD","IE00BLSP4239.USD","GDOC","BK4501","LU0661504455.SGD","LU0289739343.SGD","LU1032955483.USD","IXJ","LU1674673691.USD","SG9999003800.SGD","LU0985481810.HKD","LU2129689514.USD","SG9999001440.SGD","LU0689472784.USD","LU1221951046.USD","IYH","LU0321505868.SGD","LU2602419157.SGD","LU0345770993.USD","LU2089984988.USD","MEDX","LU2471134952.CNY","LU0210536198.USD","LU2487616109.SGD","IE000WAW04H5.SGD","LU0426412945.USD","LU0738911758.USD","LU0225771236.USD","IE0009355771.USD","LU1261432733.SGD","JDOC","LU2592432038.USD","SG9999002224.SGD","LU1989771016.USD","IE00BZ1G4Q59.USD","LU0466842654.USD","LU1914381329.SGD","IE00B3PB1722.GBP","LU0306807586.USD","LU1196500208.SGD","LU1043141396.HKD","LU2750360997.AUD","LU0472753341.HKD","BK4007","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","LU2456880835.USD","VHT","SG9999013999.USD","MRNX","IE000SO60NU8.SGD","LU1057294990.SGD","LU1280957306.USD","SG9999002232.USD","LU1244550221.USD","LU1929549753.HKD","FHLC","JNJ","BK4592","IE00BLSP4452.SGD","LU1066051811.HKD","IE00BJJMRZ35.SGD","LU0162691827.USD","LU2403377893.USD","LU0456855351.SGD","LU0070217475.USD","LU1674673428.USD","LU0820561818.USD","LU1066051498.USD","SG9999001176.USD","IE000MB6IJN5.SGD","LU1059921491.USD","IE0000B7K699.USD","LU1267930813.SGD","LU1732800096.USD","LU2756315318.SGD","BK4533","LU0511384066.AUD","IE00BVYPNW00.USD","LU0170899867.USD","BMED","LU0545039389.USD","LU1145028129.USD","IE00BVYPNV92.GBP","LU2430703095.HKD","LU2596442595.SGD","BK4550","IE00BFTCPJ56.SGD","IE0034235303.USD","LU0203347892.USD","IE00BFXG1179.USD","LU0320765646.SGD","LU1718418525.SGD","LU1894683264.USD","IE0001KFT4U8.USD","BK4535","LU2213496289.HKD","IE00BGHQF631.EUR","LU0640476718.USD","LU2471134796.USD","SGXZ80539844.SGD","WDNA","LU2430703178.SGD","LU0306806265.USD","TRUH","LU2430703251.USD","LU1629891620.HKD","LU0795875169.SGD","RXL","LU2505996681.GBP","MRNA","LU0124676726.USD","LU0912757837.SGD","LU0122379950.USD","LU1244550494.USD","SG9999001176.SGD","LU0432979614.USD","IE00B4R5TH58.HKD","LU0689626769.HKD","BK4551","LU1506573853.SGD","IE00B2B36J28.USD","LU0964807845.USD","LU0985320562.USD","LU0820561909.HKD","LU0426417589.USD","LU1732799900.SGD","BK4581","LU0069063385.USD","GNOM","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963269","title":"拜耳(BAYRY)腎病藥物可仁達®獲FDA批新適應症 填補1型糖尿病併發症30年空白","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963269","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963269?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 17:35","pubTimestamp":1789637756,"startTime":"0","endTime":"0","summary":"本次获批使可仁达成为30多年来首个获批用于治疗1型糖尿病相关慢性肾脏病的创新疗法。这是FDA批准该药的第三个适应症,进一步奠定了其在心肾并发症治疗领域的市场地位。拜耳方面表示,可仁达作为目前唯一获批可同时覆盖1型和2型糖尿病相关慢性肾脏病的口服每日一次MRA药物,将有效填补长期以来的临床空白,并持续巩固公司在心血管及肾脏疾病领域的全球领跑优势。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/MWM3M2E1ZjMzOTEwODk1MDE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MWM3M2E1ZjMzOTEwODk1MDE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306150","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4585","BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667019786","title":"阿波羅(APO)聯合KKR(KKR)完成對拜耳(BAYRY)30億歐元資本解決方案交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2667019786","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667019786?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 17:27","pubTimestamp":1789550861,"startTime":"0","endTime":"0","summary":"金吾财讯 | 阿波罗全球管理 宣布,已与知名私募股权机构KKR共同完成了对德国生命科学巨头拜耳价值30亿欧元的资本解决方案交易。根据交易安排,阿波罗联合作为重要少数股权投资方加入的KKR,共同向一家新成立的实体注入股权资本。该实体持有拜耳的长效可逆避孕药业务。阿波罗合伙人Jamshid Ehsani表示,此项定制化的数十亿欧元资本方案符合其“投资级资本解决方案”业务的发展方向。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/ZmFlOWFhNTNlYzgzMTc4NTEyNzIzMzYzNzY2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZmFlOWFhNTNlYzgzMTc4NTEyNzIzMzYzNzY2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306094","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00B775SV38.USD","LU1935042991.SGD","LU0130102774.USD","LU1935043023.USD","PRVT","BK4585","BK4184","IE00B64PRP62.GBP","LU1323610961.USD","LU1935042215.USD","AAUM","BK4007","LU1668664300.SGD","BAYRY","LU0683600562.USD","KKR","LU1791807156.HKD","LU0106831901.USD","NBIE","FXE","LU0787776722.HKD","IE00B3S45H60.SGD","LU0648001328.SGD","LU1935043536.SGD","APO","EURmain","LU0314104364.USD","EUO","IE0002270589.USD","BK4135","LU0006061336.USD","IE00B19Z3B42.SGD","PSP","LBO","MEURmain","GPZ","BK4588","LU0980610538.SGD","LU1201861249.SGD","IE00B19Z3581.USD","LU1935042488.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656007535","title":"拜耳(BAYRY)二季度Non-GAAP每股盈利達0.95歐元勝預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2656007535","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656007535?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 16:16","pubTimestamp":1785831386,"startTime":"0","endTime":"0","summary":"金吾财讯 | 德国医药与农化巨头拜耳 发布2026财年第二季度财报。数据显示,二季度公司Non-GAAP每股收益达0.95欧元,超出市场预期0.20欧元;扣除特殊项目前的息税折旧及摊销前利润同比增长1.9%至21.44亿欧元。基于2026年6月30日的最新汇率预估,拜耳将全年集团销售额指引微调至447亿至467亿欧元,核心每股收益指引上调至4.20至4.70欧元。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/ZTU0NWNjNjJlNDMyOWFlYTQ0MTc4YmQzNzNjNjM2NzgyMTUxODUw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZTU0NWNjNjJlNDMyOWFlYTQ0MTc4YmQzNzNjNjM2NzgyMTUxODUw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303360","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEURmain","FXE","EURmain","BK4007","BAYRY","EUO","NBIE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119758865","title":"財報前瞻|Bayer A.G.本季度營收預計降4.47%,機構觀點偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1119758865","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119758865?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 08:59","pubTimestamp":1785200374,"startTime":"0","endTime":"0","summary":"Bayer A.G.计划于2026年08月04日发布最新季度财报,市场关注作物科学与制药板块的贡献与法律事项进展对盈利质量的影响。市场一致预期显示,本季度Bayer A.G.营收预计为123.05亿美元,同比下降4.47%;调整后每股收益预计为0.25美元,同比持平0.00%;同时,息税前利润预计为13.30亿美元,同比增长7.53%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻|Bayer A.G.本季度营收预计降4.47%,机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650864191","title":"拜耳(BAYRY)旗下長效可逆避孕業務引入阿波羅(APO)30億歐元戰略投資","url":"https://stock-news.laohu8.com/highlight/detail?id=2650864191","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650864191?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 17:21","pubTimestamp":1783675288,"startTime":"0","endTime":"0","summary":"金吾财讯 | 德国制药巨头拜耳 官宣与私募巨头阿波罗旗下基金达成股权融资协议,针对旗下长效可逆避孕业务完成 30 亿欧元募资,拜耳牢牢守住业务主导权,同步优化集团资产负债表。交易架构方面,双方设立专属主体承接曼月乐等长效避孕资产,阿波罗及关联方仅获取无控制权少数股权,拜耳持有多数股份并保留完整经营决策权。拜耳 LARC 产品线市场需求稳健,近年全球销售额保持双位数增长,是集团女性健康板块稳定现金流来源。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/ZTQwNTFmNGU4NDI5MjlhNTQyNjBlMmZkZmU5ZTE0MDcxNDc2MTczODk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTQwNTFmNGU4NDI5MjlhNTQyNjBlMmZkZmU5ZTE0MDcxNDc2MTczODk=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302430","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3S45H60.SGD","EUO","IE0002270589.USD","EURmain","LU1323610961.USD","APO","LU0106831901.USD","LU0683600562.USD","LBO","LU0787776722.HKD","BK4184","LU1668664300.SGD","LU1791807156.HKD","BK4135","MEURmain","IE00B19Z3B42.SGD","LU0006061336.USD","BAYRY","IE00B775SV38.USD","IE00B19Z3581.USD","BK4007","FXE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648409502","title":"拜耳(BAYRY)拆分美國草甘膦業務設立全資子公司 全新實體優化農化市場運營","url":"https://stock-news.laohu8.com/highlight/detail?id=2648409502","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648409502?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 19:50","pubTimestamp":1782993033,"startTime":"0","endTime":"0","summary":"新实体独立负责美国草甘膦产品定价、生产调度、物流配送与市场推广全流程业务,拥有完整业务自主决策权。原归属集团的美国草甘膦专属产品团队、销售渠道全部划转至 Ruveon,持续为本土农业市场供应除草剂产品。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302142","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646359721","title":"美國最高法院裁定拜耳(BAYRY)在「農達」除草劑訴訟案中勝訴","url":"https://stock-news.laohu8.com/highlight/detail?id=2646359721","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646359721?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 18:46","pubTimestamp":1782470798,"startTime":"0","endTime":"0","summary":"金吾财讯 | 美国最高法院新近做出了一项重磅裁决,以7比2的投票结果支持跨国医药与农资巨头拜耳 ,推翻了此前下级法院判定其“农达”除草剂致癌并赔偿125万美元的判决。鉴于美国环保署此前已认定农达的核心成分草甘膦不属于致癌物,并批准了该产品的销售标签,拜耳理应免受各州法院关于“未尽告知义务”的诉讼索赔。分析人士指出,自2018年收购孟山都以来,拜耳便深陷“农达”致癌的诉讼泥潭,至今已支付了数十亿美元和解金。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/NDFhNjFhNTY0NDg0M2I4OWYyMjllMGMzMjhkNzg4NjU0MjU3NDEyMzM0.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDFhNjFhNTY0NDg0M2I4OWYyMjllMGMzMjhkNzg4NjU0MjU3NDEyMzM0.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301954","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645020687","title":"拜耳(BAYRY)與Iambic攜手利用AI加速藥物研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2645020687","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645020687?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 21:28","pubTimestamp":1782134886,"startTime":"0","endTime":"0","summary":"拜耳将全面引入Iambic的前沿AI研发平台,共同聚焦于小分子药物的发现与优化,以期攻克此前被行业视为“不可成药”的疾病靶点,为拜耳的早期研发管线注入创新动力。根据协议,拜耳将获得Iambic旗下顶尖的前沿AI模型Enchant和NeuralPLexer的使用权。同时,Iambic将获得一笔首付款,并在未来有权获得基于特定里程碑的开发款项及上市后的销售特许权使用费。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301761","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","AGIX","ARTY","BK4007","CHAT","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640457729","title":"拜耳(BAYRY)股價承壓下行 與農達除草劑和解協議面臨新的法律挑戰","url":"https://stock-news.laohu8.com/highlight/detail?id=2640457729","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640457729?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 21:15","pubTimestamp":1780406103,"startTime":"0","endTime":"0","summary":"金吾财讯 | 拜耳 股价承压下行,报9.68美元,跌4.63%。消息面上,拜耳受农达除草剂和解案件管辖权变动拖累,欧洲盘中股价下挫约 5%,年内个股跌幅逼近 10%。拜耳今年 2 月敲定赔付方案,计划分 20 年完成赔款兑付,大额资金集中在本年度支出,以此一次性了结存量及后续潜在致癌相关索赔。多区诉讼司法小组裁定变更审理法院后,拜耳明确将提请上诉,而原告退出和解的截止日期已近在咫尺。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210625/OGIwZDQyMDYwMGIwOWQ1NTkxMDE1Mzc1NTA2MDQ=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OGIwZDQyMDYwMGIwOWQ1NTkxMDE1Mzc1NTA2MDQ=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301084","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637342543","title":"拜耳(BAYRY)新藥獲FDA優先審評 腎科用藥版圖擴容","url":"https://stock-news.laohu8.com/highlight/detail?id=2637342543","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637342543?lang=zh_tw&edition=fundamental","pubTime":"2026-05-21 22:10","pubTimestamp":1779372601,"startTime":"0","endTime":"0","summary":"金吾财讯 | 拜耳 宣布,其肾病治疗药物 Kerendia的补充新药申请获美国 FDA 受理并授予优先审查资格,用于治疗 1 型糖尿病相关慢性肾病成年患者。结果显示,非奈利酮可显著降低患者尿白蛋白与肌酐比值,这一指标是评估 1 型糖尿病合并慢性肾病患者肾脏事件的核心预测因子Bayer。若本次新适应症顺利获批,Kerendia 将成为首款针对 1 型糖尿病相关慢性肾病的盐皮质激素受体拮抗剂,填补临床治疗空白。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300702","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4007","BK4588","BK4585","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636836985","title":"拜耳(BAYRY)新藥獲FDA優先審評 聚焦二次中風預防","url":"https://stock-news.laohu8.com/highlight/detail?id=2636836985","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636836985?lang=zh_tw&edition=fundamental","pubTime":"2026-05-19 16:10","pubTimestamp":1779178215,"startTime":"0","endTime":"0","summary":"值得注意的是,asundexian 在 2023 年已获得 FDA 快速通道资格,此次优先审评资格的授予,进一步凸显了该药物在二次中风预防领域的潜在价值。FDA 的优先审评资格,主要授予那些获批后能显著提升严重疾病治疗、预防或诊断安全性与有效性的药物。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300574","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4007","LABU","BAYRY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635726945","title":"律師們在拜耳72.5億美元和解案中爭取接近紀錄的律師費","url":"https://stock-news.laohu8.com/highlight/detail?id=2635726945","media":"路透中文","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635726945?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 04:40","pubTimestamp":1778791255,"startTime":"0","endTime":"0","summary":"律师们在拜耳72.5亿美元和解案中争取接近纪录的律师费拟议的费用将超过近期几笔巨额费用裁决内幕交易案暴露律所安全漏洞谷歌反对在安卓隐私案中支付4000万美元律师费David Thomas/Mike Scarcella/Karen Sloan. )若密苏里州法官批准,针对拜耳公司“农达”除草剂案、正在协商中的72.5亿美元和解协议,原告律师拟获得的酬金可能成为有史以来最高的律师费裁决之一。她最终裁定向律师支付3.45亿美元,这是特拉华州有史以来最高的律师费裁定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL4S41R208:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109391861.USD","LU1720051017.SGD","LU2250418816.HKD","BK4602","LU0690374615.EUR","LU1852331112.SGD","LU0640476718.USD","TSLO","LU1496350502.SGD","GOOGL","IE0001KFT4U8.USD","TSLI","LU2275660780.HKD","LU1861220033.SGD","LU0107464264.USD","LU1435385759.SGD","LU0957791311.USD","LU1366333091.USD","SGXZ51526630.SGD","LU0345769631.USD","LU1571399168.USD","LU2097344357.USD","LU1084165304.USD","LU0061474705.USD","LU2023251221.USD","LU1839511570.USD","LU0354030438.USD","LU2028103732.USD","LU2290526834.HKD","LU2077746001.SGD","LU0175139822.USD","BK4099","BK4598","LU2168564495.EUR","SG9999014880.SGD","IE00BMPRXR70.SGD","TSL","LU0820561818.USD","LU2097344431.USD","LU2089284900.SGD","IE00BDRTCR15.USD","LU1506573853.SGD","LU1861215975.USD","LU2213496289.HKD","LU2381873111.SGD","LU1868837136.USD","GOOP","LU2023250504.SGD","LU2471134523.USD","LU1232071149.USD","TSDD","LU0477156953.USD","SG9999014542.SGD","BK4077","HK0000532082.HKD","LU2360106780.USD","LU0353189680.USD","LU0210533765.USD","LU2462157665.USD","LU2111349929.HKD","LU0133085943.USD","LU0661504455.SGD","LU1429558221.USD","IE00BKVL7J92.USD","GB00B4QBRK32.GBP","LU0048573561.USD","LU1804176565.USD","LU0648000940.SGD","LU1221951046.USD","LU0256863902.USD","LU1400636491.USD","LU1496350171.SGD","LU2023250843.SGD","LU0048584097.USD","LU0210536198.USD","BK4612","LU0553294199.USD","LU1868836757.USD","LU2089283258.USD","IE00B19Z3581.USD","LU0689472784.USD","LU0949170772.SGD","IE00BFMHRM44.USD","LU2471134952.CNY","LU0314104364.USD","LU1400636574.HKD","LU1235294995.USD","IE00BLSP4239.USD","LU2746668974.SGD","LU0096362180.USD","BK4588","LU0348723411.USD","LU0738911758.USD","LU0203347892.USD","LU2168564149.EUR","LU1196500208.SGD","LU0823434740.USD","LU2097829019.USD","LU2491050154.USD","LU0256863811.USD","LU2092937148.SGD","LU0690374961.EUR","LU0061474960.USD","LU2491049909.HKD","HK0000304797.USD","IE00BKPKM429.USD","LU1674673428.USD","SG9999015986.USD","LU2430703251.USD","LU0211331839.USD","LU1202635105.USD","LU1116320901.HKD","IE00BKDWB100.SGD","LU1267930730.SGD","LU0882574139.USD","LU0130102774.USD","LU0494093205.USD","LU2211815571.USD","SGXZ31699556.SGD","LU1043141123.HKD","LU2125909247.SGD","LU0225283273.USD","IE00BJTD4N35.SGD","LU0545039389.USD","LU1629891620.HKD","LU0353189763.USD","LU0476273544.USD","GOOW","LU0211326839.USD","LU0823421416.USD","LU0289960550.SGD","LU0719512351.SGD","LU1974910355.USD","LU2433249047.HKD","LU1989764664.SGD","LU0466842654.USD","SG9999015341.SGD","LU0708995401.HKD","IE00BQXX3C00.GBP","LU0143551892.USD","LU0444973449.USD","LU0868494708.USD","GOOX","LU1989764748.USD","SG9999015358.SGD","LU0251131958.USD","LU0211328371.USD","IE00BK4W5L77.USD","LU0106261372.USD","LU1935042488.USD","LU0310800379.SGD","LU0029864427.USD","LU2505996681.GBP","BK4548","GGLL","SG9999014575.USD","IE00B19Z8W00.USD","LU1988902786.USD","LU1244550494.USD","LU2168564222.USD","LU1066051225.USD","LU2191332357.HKD","TSLL","BK4503","LU2360107168.USD","IE0004086264.USD","LU0345768740.USD","IE00BLSP4452.SGD","LU0689626769.HKD","LU0170899867.USD","BK4576","LU1153585028.USD","LU1145028129.USD","LU2756315664.SGD","IE0034235295.USD","LU1951200564.SGD","LU2750360641.GBP","LU2746668461.USD","SG9999014567.USD","LU0985320562.USD","LU0345770993.USD","LU0320765489.SGD","LU2505996509.AUD","BK4551","LU0080751232.USD","LU1935043536.SGD","LU0742534661.SGD","LU1861558580.USD","LU0130517989.USD","LU1201861165.SGD","LU1868836591.USD","BK4533","LU0820562030.AUD","IE00BZ1G4Q59.USD","LU2242649171.HKD","BK4543","LU0976567544.SGD","LU0289961442.SGD","GOU","TSLR","LU0082616367.USD","LU2236285917.USD","BK4532","IE00B1XK9C88.USD","LU1121112475.USD","IE000SO60NU8.SGD","LU0198837287.USD","BK4534","LU0061475181.USD","LU0265550359.USD","IE00BDCRKT87.USD","LU1670627923.USD","LU0957808578.USD","LU1778281490.HKD","LU2023250330.USD","LU0154236417.USD","LU2326559502.SGD","LU0345774391.USD","LU0323591593.USD","LU0823411888.USD","LU2108987350.USD","LU0823434583.USD","LU0203345920.USD","LU0302445910.USD","LU2362541273.HKD","LU0342679015.USD","LU0708994859.HKD","LU1935042215.USD","LU0444971666.USD","LU2417539215.USD","LU1670628061.USD","SG9999014559.SGD","LU0820561909.HKD","LU0889566641.SGD","LU0980610538.SGD","LU0642271901.SGD","LU2362541513.USD","LU0211327993.USD","LU0234570918.USD","LU0472753341.HKD","LU0158827781.USD","LU1894683348.USD","LU0052756011.USD","SG9999017495.SGD","BK4555","LU2125154778.USD","BK4604","IE00BK4W5M84.HKD","IE00BYXW3230.USD","IE000WAW04H5.SGD","LU2168564065.EUR","HK0000304805.HKD","SGXZ81514606.USD","LU1791710582.SGD","LU0251142724.SGD","LU0792757196.USD","IE00BBT3K403.USD","LU0157215616.USD","IE00B19Z3B42.SGD","LU0345770308.USD","LU0097036916.USD","IE00BJLML261.HKD","LU2125154935.USD","IE0034235303.USD","LU0128525929.USD","LU2860962120.EUR","LU1923623000.USD","LU0310800965.SGD","LU1267930813.SGD","LU1894683264.USD","BK4573","LU0128525689.USD","LU0477156797.USD","LU1585245621.USD","LU2404859741.USD","LU2244417387.USD","LU1718418525.SGD","LU0787776722.HKD","LU0942090050.USD","LU0053666078.USD","LU0130103400.USD","LU0265550946.USD","LU1316542783.SGD","IE00B7SZLL34.SGD","LU0823421333.USD","LU1267930227.SGD","LU2264538146.SGD","LU2403377893.USD","LU0234572021.USD","LU1430594728.SGD","LU0211326755.USD","LU1791710400.SGD","IE00BMPRXQ63.HKD","LU2471134796.USD","LU1043141396.HKD","LU1267930490.SGD","BK4511","LU1280957306.USD","LU1548497426.USD","LU1951198990.SGD","SG9999015945.SGD","IE000BZT7R73.USD","LU0345769128.USD","LU0070217475.USD","LU1066051498.USD","TSLG","LU0057025933.USD","LU1880398471.USD","LU2430703178.SGD","LU0077335932.USD","LU2430703095.HKD","TLA","LU1201861249.SGD","LU0784385840.USD","LU2054465674.USD","LU0672654240.SGD","LU0784385170.HKD","TSLA","LU1823568750.SGD","LU2602419157.SGD","GB00B4LPDJ14.GBP","LU0056508442.USD","LU1267930573.SGD","LU1244550221.USD","LU2125909593.SGD","SG9999015978.USD","TSLS","LU0069063385.USD","GOOY","LU0187121727.USD","LU1059921491.USD","LU2168563687.JPY","TSLZ","TSLT","TSLW","LU1815333072.USD","LU0158827948.USD","LU1803068623.USD","TSLQ","BK4592","IE0002270589.USD","LU0426412945.USD","LU1699723380.USD","LU1642822529.SGD","LU1551013342.USD","IE00BJTD4V19.USD","LU1244550577.SGD","SG9999014898.SGD","LU2420271590.USD","LU2242650005.HKD","LU0426417589.USD","LU2065171402.SGD","IE00BWXC8680.SGD","LU0784383803.USD","LU2999663052.SGD","GGLS","LU0276348264.USD","LU0964807845.USD","LU1674673691.USD","LU0006306889.USD","IE00BQXX3F31.USD","LU0528227936.USD","LU0511384066.AUD","LU1066051811.HKD","BK4550","LU2271345857.HKD","LU0949170426.SGD","LU2092627202.USD","LU1914381329.SGD","LU1551013425.SGD","LU0417517546.SGD","LU1670756490.USD","LU0784384876.USD","SG9999014906.USD","LU0070302665.USD","LU0823414478.USD","LU2237438978.USD","LU0994945656.USD","LU0320765059.SGD","IE00BMPRXN33.USD","LU0345774631.USD","LU2360032135.SGD","LU0096364046.USD","IE00B19Z8X17.USD","LU1989772840.SGD","IE00B1BXHZ80.USD","SG9999018857.SGD","HK0000819398.USD","LU1221951129.SGD","LU2106854487.HKD","TSYY","LU1917777945.USD","BK4579","LU2404859667.USD","LU2896262040.SGD","LU1032955483.USD","BK4566","LU2362540622.SGD","IE00BQXX3D17.EUR","IE00BSNM7G36.USD","LU0094547139.USD","LU2471134879.HKD","LU1935043023.USD","LU0215105999.USD","LU2491050071.SGD","TESL","TSLP","LU2462591350.SGD","SG9999015952.SGD","BK4514","LU0316494557.USD","LU0251132253.USD","TSII","LU2098885051.SGD","LU0310799852.SGD","LU2756315318.SGD","IE000MB6IJN5.SGD","LU1303367103.USD","LU1064131342.USD","IE00B19Z9505.USD","LU0138981039.USD","LU0345768153.USD","LU0149725797.USD","LU2087625088.SGD","LU2247934214.USD","IE00BHPRN162.USD","LU2065170008.USD","CRSH","LU1323610961.USD","LU2456880835.USD","LU0943347566.SGD","LU2065169927.USD","LU0289739343.SGD","LU0174119429.USD","LU0314106906.USD","LU0312595415.SGD","BK4574","LU1116320737.USD","BK4527","LU2954938101.SGD","LU0267386448.USD","LU2249611893.SGD","LU1301847155.USD","SGXZ99366536.SGD","IE0034235188.USD","LU0648001328.SGD","LU2265009873.SGD","LU2087621335.USD","LU1720051108.HKD","LU1923622614.USD","LU0868494617.USD","MMM","LU1119994496.HKD","LU1989772923.USD","LU1046421795.USD","LU0127658192.USD","LU2462591277.SGD","IE000F7OJYX1.SGD","LU0354030511.USD","SG9999018865.SGD","BAYRY","BK4561","LU0130518102.USD","LU0496365809.HKD","LU1815336760.USD","LU1880398554.USD","BK4585","LU2750360997.AUD","07766","LU1868837300.USD","LU1261432733.SGD","IE0000B7K699.USD","SG9999014914.USD","LU1868836914.USD","LU0557290698.USD","LU0011850046.USD","LU1003077747.HKD","LU1935042991.SGD","LU2063271972.USD","LU1633808545.USD","LU0124676726.USD","LU0683600562.USD","BK4581","LU0208291251.USD","LU1066053197.SGD","LU1861559042.SGD","IE00BN8TJ469.HKD","BK4538","LU1645745479.HKD","LU2592432038.USD","TEST","LU2065171311.SGD","BK4516","SG9999000418.SGD","LU1400636657.SGD","LU2357305700.SGD","IE0004091025.USD","TSLY","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}